To determine whether decreased cardiac parasympathetic activity observed in obesity is due to insulin-induced alterations in cardiac M 2 -muscarinic receptors and/or adenylyl cyclase activity. DESIGN AND METHODS: After incubation with increasing concentrations of insulin, adult rat atrial cardiomyocytes were assayed for M 2 -muscarinic receptor binding density and affinity, and for M 2 R mRNA expression using RT-PCR analysis. Forskolinstimulated adenylyl cyclase activity and its inhibition by carbachol were also assayed, as was endothelial nitric oxide synthase mRNA expression. The effects of insulin on M 2 -muscarinic receptor density and mRNA expression levels were analyzed using the insulin signaling inhibitors rapamycin, wortmanin and PD 098059. RESULTS: Insulin induces a concentration-and time-dependent decrease in expression of the M 2 R mRNA, and in [ 3 H]Nmethylscopolamine binding by the receptor. These effects on the M 2 R mRNA levels and on [ 3 H]N-methylscopolamine binding were prevented by PD 98059, but not by wortmanin or rapamycin. Basal and forskolin-induced cAMP production did not differ, but the inhibition of forskolin-simulated enzyme activity by carbachol was blunted by insulin. No change in the mRNA levels for endothelial nitric oxide synthase was observed. CONCLUSION: In rat atrial cardiomyocytes, insulin markedly alters both the M 2 -muscarinc receptor density, and its mRNA expression through transcriptional regulation and adenylyl cyclase activity. These data suggest that the obesity-associated decrease in cardiac parasympathetic tone may be related to hyperinsulinemia, which could directly contribute to cardiovascular morbidity in obese patients.
Introduction
Obese patients have an increased mortality risk due to cardiovascular complications such as hypertension, 1 congestive heart failure 2 or sudden cardiac death. 3 Epidemiological studies (ie the Framingham study) have established these associations. However, the identification of factors linking obesity to cardiac disease still remains a matter of controversy. Changes in autonomic nervous system (ANS) activity associated with obesity could explain these cardiac complications. Until now, most findings have incriminated an overactivity of the sympathetic system per se, induced by circulating factors such as leptin. 4, 5 insulin 6 or free fatty acid. 7, 8 However, another hallmark factor is the decreased cardiac parasympathetic activity frequently reported in obese patients. [9] [10] [11] This could, like sympathetic overactivation, explain the tachycardia and the increased risk of cardiovascular mortality through hypertension and sudden cardiac death 9, 12 in obese patients. Using a canine model of dietary-induced obesity (dogs fed a high-fat diet), which mimics many of the characteristics of human obesity, [13] [14] [15] we observed atrial muscarinic receptor downregulation 16 and a decreased high frequency power (HF) of heart rate variability (HRV), which reflects cardiac parasympathetic activity. Both of these modifications led to tachycardia, and demonstrate a defective cardiac parasympathetic system. In our model, the plasma insulin level increased early, simultaneously with the installation of arterial hypertension 13 and a strong decrease in HRV. 17 We also demonstrated that these changes were tissue specific (occurring mainly in the atria) and associated with profound changes in cardiac gene expression. 18 Human studies have shown that in obese patients parasympathetic withdrawal is correlated with hyperinsulinemia. 19, 20 Taken together, these studies suggest that obesity with hyperinsulinemia is associated with defects in the cardiac parasympathetic nervous system. However, neither of these studies was designed to determine which mechanism was incriminated in obesity-related parasympathetic impairment. Therefore, we carried out experiments to determine whether insulin could directly affect the expression (M 2 R mRNA level, cardiac M 2 R density (B max )) and signaling functions (M 2 R affinity) of the cardiac muscarinic cholinergic receptor (M 2 R) in rat atrial myocytes. This study is aimed at understanding the molecular basis of the suppression of cardiac parasympathetic tone in patients with obesity and hyperinsulinemia.
Materials and methods

Animals
Adult male WISTAR rats (180-200 g, obtained from HARLAN, France) were used in this study. Animal care was in strict accordance with the guiding principles of the French Ministry of Agriculture. All experiments were carried out on animals kept under standard laboratory conditions and fed ad libitum with standard granulated food and free access to tap water.
Atrial cardiomyocyte cell cultures
Briefly, rats were anaesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg) and were pretreated with intraperitoneal heparin (2000 U/kg). The hearts were rapidly excised and the atria were removed, cut into small pieces, then washed in a calcium-free Kreb's solution (5 Â solution: 10 mM Hepes, 34.88 mM NaCl, 10 mM D-glucose, 134 mM sucrose, 24.9 mM Na 2 HPO 4 , 24.9 mM NaHCO 3 , 4.4 mM KCl and 1.18 mM KH 2 PO 4 , in 250 ml of sterile water) supplemented with 30 mM 2-3 butanedionemonoxine. All steps were carried out at 371C, with continuous gassing with 95% O 2 and 5% CO 2 and gentle agitation. After 5 min, the supernatant was discarded and the atria were digested in a solution containing collagenase (0.26 mg/ml), protease (0.3 mg/ml) and BSA (1 mg/ml) for 15 min. The supernatant was again discarded and tissue digested with collagenase (1.25 mg/ml in a Kreb's solution þ 5 mg/ml BSA) for an additional 10 min. The final supernatant was then collected, filtered and centrifuged (700 rpm, 3 min at 371C). The pellet was resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, nonessential amino acids and antibiotics (100 IU/ml penicillin and 0.1 mg/ml streptomycin). The remaining tissues, which had been processed in the same way, were digested for another 10 min and the resulting cell suspension was resuspended in a DMEM solution containing a progressively increasing calcium concentration. Wells plates, pretreated with laminin 2 h before use, were rinsed with DMEM. The cells were then distributed in six wells (4-5 Â 10 5 cells/well) and after a 4 h incubation were washed and suspended in a fetal calf serum-free medium containing DMEM, nonessential amino acids, cytosine b-Darabino-furanoside (10 mM) and a 1% penicillin streptomycin mix (1 mg/ml). The cells were incubated at 371C in a humidified atmosphere of 95% air and 5% CO 2 . Freshly isolated cells are striated and cylindrical in shape, typical of intact heart muscle. When placed in culture, some of these cells rounded up. Microscopic examination of the cells over 24 h showed that 85% of the cells were rod shaped and undamaged at the ultrastructural level at this time, as described in other reports. 21 In a number of experiments, specific signaling inhibitors were employed. Cells were pretreated with these agents before exposure to insulin (10 À8 M) using the following concentrations and times: 100 nM wortmanin for 30 min; 50 nM rapamycin for 30 min or 50 mM PD 098059 for 60 min. The concentrations of the signaling inhibitors used were chosen to completely inhibit the relevant target protein without interference with other processes. Wortmanin inhibits phosphatidylinositol-3-kinase (PI 3-kinase) 22 ; rapamycin exhibits a specific inhibitory effect on p70S6k, possibly involving a mammalian target of rapamycin (mTOR signaling), 23 and PD 098059 inhibits activation of the mitogen-activated protein kinase (MAPK) pathway.
24
Reverse transcription-polymerase chain reaction (RT-PCR) Total RNAs were extracted from atrial cardiomyocytes using the Trizol reagent (Invitrogen) following the instructions of the manufacturer and then treated with RNAse-free DNAse to eliminate genomic DNA. Total RNAs were reverse transcribed in the presence of random primers and Superscript II enzyme (Invitrogen) according to the manufacturer's protocol. Gene-specific primers were designed using Primer Express software (Applied Biosystems) based on sequence data from the National Center for Biotechnology Information databases, USA. The forward primer sequence for M 2 R was CCTCCCCTTGAACACAGGTT, and the reverse primer sequence was ATGGCGGCCTGGAACAC. Real-time PCR reactions were carried out with Sybergreen PCR Master Mix (Applied Biosystems) in a GenAmp 5700 apparatus. The standard curve method was used for the relative quantification of the PCR products and gene expression was normalized to 18S RNA quantification. 
]NMS) ranging from 0.125 to 5 nM for 2 h at 251C. Nonspecific binding was defined as the radioactivity bound to cells that could not be displaced by high concentrations of methoctramine (400 mM), a selective antagonist of the M 2 R. After 2 h, the reaction was stopped with 5 ml of cold buffer followed by rapid filtration through Whatman GF/C filters. The filters were then washed twice with ice-cold incubation buffer. The radioactivity retained on the filters was measured with a Packard scintillation counter. Data were analyzed using the Scatchard plotting method, allowing us to calculate B max (fmoles/10 5 cells) and K d .
Production of cAMP
To measure the production of cAMP, cells were preincubated with 3-isobutyl-1-methylxanthine (IBMX, 100 mM) for 30 min at 371C. cAMP levels were assessed after stimulation of adenylyl cyclase by 10 mM forskolin (5 min, 371C) in cells either treated or not with insulin (1 mM). Incubations were stopped by the addition of 5% cold trichloroacetic acid (TCA). After the extraction of TCA with cold saturated ether, the samples were lyophilized, dissolved in radioimmunoassay (RIA) buffer, and used for the cAMP assay (Cayman Chemical Assay).
Drugs
Collagenase and protease used for atrial cell dissociation, Trizol reagent, cytosineb-D-arabino-furanoside, methoctramine, carbachol, isoprenaline, forskolin, wortmanin, rapamycin, palmitic acid and insulin were purchased from Sigma (L'isle d'Aeau Chesnes, France 
Statistical analysis
Data are expressed as mean7s.e.m. Multiple comparisons were realized with the use of ANOVA followed (when required) by Dunnett's post hoc test. Single comparisons between controls and cells treated with insulin were performed using a Student's t-test. A P-value of o0.05 was considered as significant.
Results
Effect of insulin on the M 2 -cholinoceptor As revealed by the RT-PCR experiments, after exposure to increasing concentrations of insulin (starting at 10 À11 M), the levels of the mRNA encoding the M 2 R were significantly decreased in cardiomyocytes, in a concentration-dependent manner ( Figure 1) . Binding experiments revealed that the M 2 R B max measured in atrial cardiomyocytes also decreased after exposure to increasing concentrations of insulin (ranging from 10 À11 to 10 À8 M) ( Insulin effect on cardiac M 2 -muscarinic receptor and signaling A Pathak et al
We also studied the second pathway involved in muscarinic receptor signal transduction, which is mediated by endothelial nitric oxide synthase. In RT-PCR experiments, insulin (from 10 À11 to 10 À8 M) did not modify levels of the mRNA encoding eNOS (data not shown).
Insulin signaling cascade
To elucidate which signaling pathway is involved in these insulin effects, atrial cardiomyocytes were pretreated with different signaling inhibitors (rapamycin, wortmanin and PD 098059) before incubation with insulin. PD 098059 Insulin effect on cardiac M 2 -muscarinic receptor and signaling A Pathak et al inhibits activation of the MAPK pathway. 24 Treatment with the inhibitors alone failed to modify levels of the mRNA encoding M 2 R. PD 098058, a synthetic inhibitor of MAPK, was able to significantly abolish the effect of insulin on M 2 R m RNA expression, while wortmanin and rapamycin had no effect ( Figure 6 ). Binding assays confirmed that PD 098058 was able to abolish this insulin effect.
Influence of cell culture conditions
To distinguish between the possibilities of a direct effect of insulin on M 2 R expression or that of an indirect effect due to myocyte atrophy, we determined the state of the cell cultures in the presence and absence of insulin. Cell size, cell numbers and cellular protein content did not differ in the two cultures. Moreover, PD98059 inhibited the downregulation of M 2 R mRNA levels without affecting any of these parameters, confirming the specificity of the effect of insulin on M 2 R expression.
Discussion
The M 2 R are the main functional postsynaptic effectors of the parasympathetic limb of the cardiac autonomic nervous system and may thus account for changes in heart rate oscillations. Decreased M 2 R expression has been previously reported in left ventricular hypertrophy or chronic heart failure, two situations associated with an increased risk of cardiovascular mortality. 25, 26 Similar changes have been described in a canine model of dietary-induced obesity 17 and, following analysis of their heart rates, it has been suggested that these changes could also occur in obese patients.
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In vivo studies assessing cardiac muscarinic receptivity are limited by confounding factors such as interactions between various circulating agents (leptin, free fatty acids) and insulin. In order to directly study the effects of insulin on M 2 R expression, we performed this in vitro study using atrial cardiomyocytes. The rationale behind this choice is threefold. Firstly, the M 2 R are predominantly expressed in the atria and in the sinus node tissue (ie in the anatomical regions involved in heart rate regulation). Secondly, studies in tissues isolated from M 2 R knockout mice unambiguously demonstrate that these receptors play key roles in the control of heart rate. 28 Finally, dietary-induced obesity causes marked changes in gene expression in the right atrium, contributing to early changes in heart function such as tachycardia or depressed parasympathetic function. 18 This study confirms our previous report that muscarinic signaling modifications in a canine diet-induced obesity model may be related to hyperinsulinemia. 29 More generally, our results suggest that in animal models of dietary-induced obesity many cardiovascular characteristics (tachycardia, hypertension, decreased HRV) could be explained by a defect in parasympathetic signaling, which leads to a concomitant relative increase in the sympathetic tone. These results suggest that despite an unmodified b adrenergic system in diet-induced obesity models, the cardiovascular changes can be partly explained by insulin-related parasympathetic dysfunction. 30, 31 Heterologous regulation of the M 2 R has not been extensively studied and the mechanisms involved are not entirely characterized. 32 Many factors such as cytokines and trophic factors (ie insulin, growth hormone) could potentially modify M 2 R expression via transcriptional regulation. 32 In this study, we confirm this mechanism for insulin. Furthermore, other insulin-like factors such as TNF or TGF b 33, 34 that are present at elevated levels in obese patients could be involved in the genesis of cardiac lesions. Like insulin, these factors also modulate gene expression via signaling through the MAPK pathway. 32, 35 Our characterization of the muscarinic signaling system in atrial cardiomyocytes could explain certain clinical features seen in obese patients with hyperinsulinemia, such as hypertension, tachycardia or increased risk of sudden cardiac death. Previous clinical studies have found that a lower parasympathetic function was associated with increasing body fat, 11, 36, 37 and that parasympathetic withdrawal in obese patients was correlated with hyperinsulinemia. 19 Moreover, evidence converges on the conclusion that abnormal variations in plasma insulin levels elicit repeated Insulin effect on cardiac M 2 -muscarinic receptor and signaling A Pathak et al episodes of parasympathetic withdrawal. 20 In lean subjects, the fasting level of insulin ranges between 5-8.10 À11 M.
Paolisso et al 38 showed that parasympathetic withdrawal was observed concomitantly with an insulin peak at 10-fold higher than this basal level. In our experiments, expression of the M 2 R mRNA began to decrease when cardiomyocytes were incubated in the presence of 10 À11 M insulin (a concentration lower than the physiological level in lean subjects), and the M 2 R density decreased when the insulin level was 10-fold higher than the basal level, the level at which parasympathetic withdrawal was observed by Paolisso et al. 38 These findings strongly suggest that hyperinsulinemia could contribute to the parasympathetic dysfunction associated with obesity through a direct effect on the M 2 R pathway.
The action of insulin on the mammalian heart has been extensively studied and mainly involves modulation of the expression patterns of genes involved in metabolism. 35 Insulin also has a cardioprotective effect through the activation of antiapoptotic pathways 39 and its ability to limit oxidative stress, 40 thus leading to the consideration of insulin as a protective hormone for cardiomyocytes. Our study suggests that this concept of insulin should be taken with caution in the setting of obesity, since insulin-induced downregulation of M 2 R activity may alter the autonomic control of the heart. However, it is possible that our observations may result from the fact that in this study cells were exposed to high insulin levels for a short period, whereas in hyperinsulinemic obese patients who are chronically exposed to this hormone this effect may be blunted by insulin resistance. It is also possible that a negative effect of insulin on the parasympathetic system could be the initial step which leads to cardiac autonomic dysfunction, since insulin peaks are known to affect the parasympathetic system 38 and are followed by other deleterious mechanisms (ie cytokine effects, sympathetic overactivity) once insulin resistance is established. The effect of insulin was time dependent, and was first detected after at least 8 h of exposure to a concentration of insulin close to the physiological range (10 À11 M, equivalent to 1 mU/ml). The abundance of the M 2 R receptor, as assessed by its binding activity (Figure 2 ), was also affected by physiological levels of insulin (1-100 mU/ml). This time course is in accordance with a transcriptional effect rather than with interactions at the level of the cell membrane such as receptor sequestration, internalization or desensitization. 41 Our analysis of the time course of the effect of insulin on expression of the M 2 R mRNA showed that the downregulation of mRNA expression preceded the decrease in receptor binding activity by approximately 4 h. Finally, we have shown that the major intracellular pathway involved in insulin signaling is the MAPK cascade. These data are coherent with the known mechanisms of M 2 R muscarinic regulation. 32 The determination of adenylyl cyclase activity gives further insight into the results of the receptor studies. The ability of carbachol to inhibit forskolin-stimulated adenylyl cyclase activity was reduced in cells incubated with insulin. The activity of adenylyl cyclase remained similar under basal conditions as well as after forskolin stimulation, thus the downregulation that we observed was not due to a change in adenylyl cyclase activity per se but could be explained by a reduction in the numbers of atrial M 2 R, or by a loss in their affinity for agonists. Decreased adenylyl cyclase activity has been observed in rat models of obesity 42, 43 and one can hypothesize that these modifications are related to an insulin-induced parasympathetic defect. We also investigated eNOS expression, another pathway described as being involved in M 2 R transduction. 44, 45 Insulin did not modify the expression of the eNOS mRNA. These results only partly explore M 2 R signal transduction since cGMP levels were not assessed. However, our results suggest that insulin-dependent downregulation of the M 2 R is able to affect the adenylyl cyclase pathway, but is not sufficient to modulate eNOS-related M 2 R transduction.
Conclusion
The main finding of this study is the demonstration that insulin is able to downregulate M 2 R expression in adult rat atrial cardiomyocytes. This time-and dose-dependent effect is the result of transcriptional regulation of M 2 R expression mediated by the MAPK pathway, and is accompanied by a detectable change in receptor function. Our study supports the hypothesis that insulin is able to regulate M 2 R expression and extends our knowledge of the neurohormonal mechanisms that lead to impaired parasympathetic control of heart rate and HRV in obese patients. Moreover, our data provide insight into the insulin-related mechanisms leading to hypertension in these patients. Finally, our study also raises new considerations regarding the late complications related to hyperinsulinemia by emphasizing that insulin may directly affect cardiac postsynaptic status. While it has frequently been suggested that vagal dysfunction in obese or diabetic patients is mainly the result of a presynaptic dysfunction, the so-called cardiac autonomic neuropathy, our study suggests that in obesity associated with hyperinsulinemia there may also be a postsynaptic cardiac lesion, namely M 2 R downregulation.
